This information was published on 2025-09-10T00:09:42 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2548063 (IR 1854723) |
| (220) |
09 Apr 2025
|
| (511) (510) |
Class 5
Antibiotics; pharmaceutical preparations, namely, vancomycin for the treatment of colitis and gastrointestinal disorders in oral solution form, powder form and diluent form; pharmaceutical preparations, namely, vancomycin for the treatment of clostridium difficile and staphylococcus aureus colitis in oral solution form, powder form and diluent form. |
| (540) | FIRVANQ |
| (550) | Word |
| (730) |
Azurity Pharmaceuticals, Inc.
|
Find out more about publications on the About page.